Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
May 10, 2010
Financial News
ImmunoGen completes follow-on
...Price: $8 Shares after offering: 66.4 million Underwriters: JPMorgan; Oppenheimer; RBC Capital Markets; Cantor Fitzgerald;
Morgan Joseph and Co.
...
Read More
Items per page:
10
1 - 1 of 1
BioCentury
|
May 10, 2010
Financial News
ImmunoGen completes follow-on
...Price: $8 Shares after offering: 66.4 million Underwriters: JPMorgan; Oppenheimer; RBC Capital Markets; Cantor Fitzgerald;
Morgan Joseph and Co.
...
Read More
Items per page:
10
1 - 1 of 1
Previous page
Next page